Extended Data Fig. 10: Change in fibrillarin distribution with Brefeldin A (BFA) treatment in HeLa cells.
From: Selective bioorthogonal probe for N-glycan hybrid structures
BFA treatment resulted in disrupted fibrillarin labeling with a detectable cytoplasmic accumulation of MM-JH-1 and fibrillarin. N = 3 independent biological replicates. Scale bar = 5 mm shown in images.
